ATH-1105

N/A

Report date: 2024/06/21 18:05:24

NME

Base Information

Drug NameATH-1105

Drug Alias NameATH-1105

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHepatocyte growth factor modulatorsHepatocyte growth factor receptor modulators

TargetsHepatocyte growth factorHepatocyte growth factor receptor

Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAthira Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal Dementia

Inactive IndicationsN/A

ATC CodeN/A